RNAC Competitors & Alternatives
Compare Cartesian Therapeutics Inc. with similar stocks in the same industry
Biotechnology
RNAC
Main Stock$9.05
Tradestie Score
57
Market Cap
$266.26M
Revenue Growth
-0.9%
Analyst Upside
+282.0%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.53
|
$297.23M | - | 49 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.01
|
$293.03M | - | 58 | Compare |
|
OMER
Omeros Corporation
|
$9.48
|
$281.75M | 8.2 | 47 | Compare |
|
DBVT
DBV Technologies S.A.
|
$16.75
|
$275.54M | - | 56 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.90
|
$275.13M | - | 49 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.11
|
$269.08M | - | 49 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$7.92
|
$258.18M | - | 52 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$29.35
|
$256.54M | - | 58 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.53
|
$211.22M | - | 56 | Compare |
More RNAC Analysis
Data updated: Jun 17, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry